Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multi-modality MRI Study on Effect to Collateral Circulation and Blood Perfusion of Acute Cerebral Infarction by Human Urinary Kallidinogenase

NCT02259738 is registered in ClinicalTrials.gov with XuanwuH 2 as lead sponsor.

NCT NCT02259738
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02259738 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multi-modality MRI Study on Effect to Collateral Circulation and Blood Perfusion of Acute Cerebral Infarction by Human Urinary Kallidinogenase
Lead sponsor
XuanwuH 2
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2013
Completion date
June 30, 2014
Enrollment
120 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cerebral infarction